- Home
- OXBR vs QNRX Comparison
OXBR vs QNRX Comparison
Compare OXBR & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OXBR | QNRX |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 9.2M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | OXBR | QNRX |
|---|---|---|
| Price | $0.90 | $3.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $20.38 |
| AVG Volume (30 Days) | 16.9K | ★ 19.2K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.78 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $2,577,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.75 | ★ N/A |
| Revenue Growth | ★ 371.98 | N/A |
| 52 Week Low | $0.65 | $3.25 |
| 52 Week High | $1.86 | $23.50 |
Technical Indicators
Market Signals| Indicator | OXBR | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.39 | 30.85 |
| Support Level | $0.70 | $3.25 |
| Resistance Level | $0.98 | $5.18 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 56.78 | 0.89 |
Price Performance
Historical ComparisonAbout OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a holding company operating complementary growth platforms across AI infrastructure and digital financial infrastructure. Through AI GridWorks, the Company is focused on developing, owning, and operating AI data centers and related infrastructure. Through SurancePlus and its reinsurance subsidiaries, Oxbridge provides tokenized real-world asset (RWA) securities and reinsurance solutions, including tokenized reinsurance offerings utilizing blockchain technology.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.